Trial Profile
An Open Multi-centre Phase III Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients Under the Age of 6 Years
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Factor IX (Primary)
- Indications Haemophilia B
- Focus Therapeutic Use
- Sponsors Bio Products Laboratory
- 17 Oct 2014 New trial record